UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension

Circulation (New York, N.Y.), 2016-06, Vol.133 (24), p.2413-2422

2016

Volltextzugriff (PDF)

Brief Report: Anti–RNPC‐3 Antibodies As a Marker of Cancer‐Associated Scleroderma

Arthritis & rheumatology (Hoboken, N.J.), 2017-06, Vol.69 (6), p.1306-1312

2017

Volltextzugriff (PDF)

Linaclotide for the treatment of refractory lower bowel manifestations of systemic sclerosis

BMC gastroenterology, 2021-04, Vol.21 (1), p.174-174, Article 174

2021

Volltextzugriff (PDF)

Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension

Circulation. Heart failure, 2013-09, Vol.6 (5), p.953-963

2013

Volltextzugriff (PDF)

My Approach to the Treatment of Scleroderma

Mayo Clinic proceedings, 2013-04, Vol.88 (4), p.377-393

2013

Volltextzugriff (PDF)

Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2010-07, Vol.182 (2), p.252-260

2010

Volltextzugriff (PDF)

Raynaud’s Phenomenon

The New England journal of medicine, 2016-08, Vol.375 (6), p.556-565

2016

Volltextzugriff (PDF)

Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis

Annals of the rheumatic diseases, 2011-06, Vol.70 (6), p.1104-1107

2011

Volltextzugriff (PDF)

Review: Evidence That Systemic Sclerosis Is a Vascular Disease

Arthritis & rheumatology (Hoboken, N.J.), 2013-08, Vol.65 (8), p.1953-1962

2013

Volltextzugriff (PDF)

Enrichment of Scleroderma Vascular Disease–Associated Autoantigens in Endothelial Lineage Cells

Arthritis & rheumatology (Hoboken, N.J.), 2016-10, Vol.68 (10), p.2540-2549

2016

Volltextzugriff (PDF)

Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans

Medicine (Baltimore), 2014-07, Vol.93 (5), p.177-185

2014

Volltextzugriff (PDF)

Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer

Annals of the rheumatic diseases, 2018-08, Vol.77 (8), p.1179-1186

2018

Volltextzugriff (PDF)

Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer

Science (American Association for the Advancement of Science), 2014-01, Vol.343 (6167), p.152-157

2014

Volltextzugriff (PDF)

Examination of Autoantibody Status and Clinical Features Associated With Cancer Risk and Cancer‐Associated Scleroderma

Arthritis & rheumatology (Hoboken, N.J.), 2015-04, Vol.67 (4), p.1053-1061

2015

Volltextzugriff (PDF)

Deficient Smad7 Expression: A Putative Molecular Defect in Scleroderma

Proceedings of the National Academy of Sciences - PNAS, 2002-03, Vol.99 (6), p.3908-3913

2002

Volltextzugriff (PDF)

Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis–Associated Versus Idiopathic Pulmonary Arterial Hypertension

Circulation (New York, N.Y.), 2018-05, Vol.137 (22), p.2360-2370

2018

Volltextzugriff (PDF)

The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma‐Associated Raynaud's Phenomenon: A Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial

Arthritis & rheumatology (Hoboken, N.J.), 2017-08, Vol.69 (8), p.1661-1669

2017

Volltextzugriff (PDF)

Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline

American journal of respiratory and critical care medicine, 2024-01, Vol.209 (2), p.137-152

2024

Volltextzugriff (PDF)

Raynaud's Phenomenon

The New England journal of medicine, 2002-09, Vol.347 (13), p.1001-1008

Wigley, Fredrick M

2002

Volltextzugriff (PDF)

Age and Risk of Pulmonary Arterial Hypertension in Scleroderma

Chest, 2003-12, Vol.124 (6), p.2098-2104

2003

Volltextzugriff (PDF)

Diastolic Dysfunction in Systemic Sclerosis: Risk Factors and Impact on Mortality

Arthritis & rheumatology (Hoboken, N.J.), 2022-05, Vol.74 (5), p.849-859

2022

Volltextzugriff (PDF)

Prediction and impact of attacks of Raynaud's phenomenon, as judged by patient perception

Rheumatology (Oxford, England), 2015-08, Vol.54 (8), p.1443-1447

2015

Volltextzugriff (PDF)

Cumulative disease damage and anti-PM/Scl antibodies are associated with a heavy burden of calcinosis in systemic sclerosis

Rheumatology (Oxford, England), 2023-11, Vol.62 (11), p.3636-3643

2023

Volltextzugriff (PDF)

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

Annals of the rheumatic diseases, 2011-01, Vol.70 (1), p.32-38

2011

Volltextzugriff (PDF)

Editorial: Clinical Trials in Raynaud's Phenomenon: A Spoonful of Sugar (Pill) Makes the Medicine Go Down (in Flames)

Arthritis & rheumatology (Hoboken, N.J.), 2017-12, Vol.69 (12), p.2256-2258

2017

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Aktive Filter

KollektionEZB Free E-Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(138)

Publikationsform

Artikel
(141)
Tagungsberichte
(1)

Sprache

Englisch
(142)

Erscheinungsjahr

n.n

Thema

Humans
(97)
Science & Technology
(97)
Life Sciences & Biomedicine
(93)
Female
(73)
Male
(72)
Middle Aged
(66)
Rheumatology
(66)
Adult
(63)
Biological And Medical Sciences
(50)
Medical Sciences
(50)
Scleroderma
(40)
Scleroderma, Systemic - Complications
(35)
Aged
(28)
Scleroderma, Systemic - Immunology
(23)
Diseases Of The Osteoarticular System
(21)
General & Internal Medicine
(18)
Scleroderma, Systemic - Physiopathology
(18)
Systemic Sclerosis
(17)
Severity Of Illness Index
(16)
Scleroderma, Systemic - Drug Therapy
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension

Brief Report: Anti–RNPC‐3 Antibodies As a Marker of Cancer‐Associated Scleroderma

Linaclotide for the treatment of refractory lower bowel manifestations of systemic sclerosis

Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension

My Approach to the Treatment of Scleroderma

Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension

Raynaud’s Phenomenon

Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis

Review: Evidence That Systemic Sclerosis Is a Vascular Disease

Enrichment of Scleroderma Vascular Disease–Associated Autoantigens in Endothelial Lineage Cells

Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans

Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer

Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer

Examination of Autoantibody Status and Clinical Features Associated With Cancer Risk and Cancer‐Associated Scleroderma

Deficient Smad7 Expression: A Putative Molecular Defect in Scleroderma

Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis–Associated Versus Idiopathic Pulmonary Arterial Hypertension

The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma‐Associated Raynaud's Phenomenon: A Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial

Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline

Raynaud's Phenomenon

Age and Risk of Pulmonary Arterial Hypertension in Scleroderma

Diastolic Dysfunction in Systemic Sclerosis: Risk Factors and Impact on Mortality

Prediction and impact of attacks of Raynaud's phenomenon, as judged by patient perception

Cumulative disease damage and anti-PM/Scl antibodies are associated with a heavy burden of calcinosis in systemic sclerosis

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

Editorial: Clinical Trials in Raynaud's Phenomenon: A Spoonful of Sugar (Pill) Makes the Medicine Go Down (in Flames)

Aktive Filter

Suchergebnisse filtern